Risk factors and clinical outcomes in patients with colistin-resistant Klebsiella pneumoniae bloodstream infection: A retrospective analysis
- 22 May 2025
- journal article
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 56, 100882
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae InfectionFrontiers in Microbiology, 2021
- Evaluation of Specific Risk Factors and Outcomes of Colistin-Resistant Klebsiella pneumoniae Infections in a Tertiary Care Centre - An Observational StudyAmerican Journal of Clinical Microbiology and Antimicrobials, 2021
- Distribution of pathogens and antimicrobial resistance in ICU-bloodstream infections during hospitalization: a nationwide surveillance studyScientific Reports, 2021
- Klebsiella pneumoniae: an increasing threat to public healthAnnals of Clinical Microbiology and Antimicrobials, 2020
- Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)Emerging Microbes & Infections, 2020
- The alarming antimicrobial resistance in ESKAPEE pathogens: Can essential oils come to the rescue?Fitoterapia, 2020
- Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistanceFEMS Microbiology Reviews, 2017
- Multidrug-Resistant Bacteria in the CommunityInfectious Disease Clinics of North America, 2016
- Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control studyClinical Microbiology and Infection, 2015
- Risk factors associated with the isolation of colistin-resistant Gram-negative bacteria: A matched case-control studyCritical Care Medicine, 2008